跳至主要内容
临床试验/NCT01892319
NCT01892319已完成不适用

An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Levemir® (Insulin Detemir) in Pregnant Women With Diabetes Mellitus

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 2,446 人开始时间: 2013年9月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
2,446
试验地点
1
主要终点
Proportion of pregnancies (Levemir® treatment), compared to pregnancies (other basal insulin treatment regimens), resulting in none of the following events: Major congenital malformations, Perinatal death, Neonatal death

研究概览

简要总结

This study is conducted in Europe and Asia. The purpose of the study (Diabetes Pregnancy Registry) is to evaluate the safety of treatment with insulin detemir in pregnant women with diabetes mellitus.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Informed consent obtained before any data collection - Woman with a positive pregnancy test - Diabetes mellitus type 1 or 2, diagnosed prior to conception - Currently treated with Levemir® or other injectable antidiabetic treatment(s) - Unchanged basal insulin or other injectable antidiabetic treatment product (for those not treated with basal insulin) 4 weeks prior to and following conception

排除标准

  • Women who have been pregnant for more than 16 weeks at baseline visit will be excluded from the study

研究组 & 干预措施

All patients

干预措施: insulin detemir (Drug)

All patients

干预措施: other injectable antidiabetic treatment regimens (Drug)

结局指标

主要结局

Proportion of pregnancies (Levemir® treatment), compared to pregnancies (other basal insulin treatment regimens), resulting in none of the following events: Major congenital malformations, Perinatal death, Neonatal death

时间窗: Assessed up to 4 weeks after delivery

次要结局

  • Proportion of pregnancies complicated by pre-eclampsia(During pregnancy)
  • Height(At the age of 1 year)
  • Proportion of pregnancies resulting in pre-term delivery(Assessed at delivery)
  • Proportion of pregnancies resulting in perinatal death(Assessed 1 week after delivery)
  • Incidence of major hypoglycaemia(During pregnancy)
  • Proportion of pregnancies resulting in neonatal death(Assessed 4 weeks after delivery)
  • Proportion of pregnancies resulting in spontaneous abortion(Assessed at pregnancy termination)
  • Weight(At the age of 1 year)
  • Proportion with changes (progression/regression) of major congenital malformations(At the age of 1 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验